Table 3:
Therapeutic mastectomies: Surgical indication and breast cancer stage.
| Autologous Fat Grafting Status | ||||
|---|---|---|---|---|
| Overall | No AFG | AFG | p | |
| Number of Mastectomies | 277 | 204 | 73 | |
| Histology Type, n (%) | 0.001† | |||
| Mixed IDC and ILC | 8 (2.9) | 8 (4.0) | 0 (0.0) | |
| LCIS | 1 (0.4) | 1 (0.5) | 0 (0.0) | |
| ILC | 18 (6.6) | 9 (4.5) | 9 (12.3) | |
| IDC | 177 (64.8) | 138 (69.0) | 39 (53.4) | |
| DCIS | 56 (20.5) | 40 (20.0) | 16 (21.9) | |
| Unknown | 13 (4.8) | 4 (2.0) | 9 (12.3) | |
| Pathologic Stage, n (%) | 0.038† | |||
| 0 | 45 (16.5) | 33 (16.5) | 12 (16.4) | |
| 1 | 88 (32.2) | 72 (36.0) | 16 (21.9) | |
| 2 | 98 (35.9) | 69 (24.5) | 29 (39.7) | |
| 3 | 18 (6.6) | 14 (7.0) | 4 (5.5) | |
| Unknown | 24 (8.8) | 12 (6.0) | 12 (16.4) | |
Statistically significant, DCIS = ductal carcinoma in situ; IDC = invasive ductal carcinoma; ILC = invasive lobular carcinoma; LCIS = lobular carcinoma in situ.